Clinical Use Cases

TBI Biomarker Testing
in Clinical Practice

Clear TBI NeuroLabs helps providers incorporate objective biomarker data into concussion and traumatic brain injury evaluation. Testing is designed to complement symptoms, imaging, neurological evaluation, and clinical judgment by adding measurable biological insight to the care process.

TBI Biomarker Testing

Where Biomarker Testing May Support Care

Blood-based biomarker testing can add another layer of information when evaluating patients after suspected concussion or traumatic brain injury. Clear TBI is designed to help providers better understand biological response, support follow-up planning, and document findings within the broader clinical picture.

Concussion Evaluation

Add objective biological data when symptoms alone do not tell the full story.

Persistent Symptoms

Support a more complete view when patients continue to experience cognitive, sensory, physical, or emotional symptoms.

Recovery Monitoring

Help providers better understand biological response over time and consider whether additional follow-up may be appropriate.

Referral Support

Provide additional context when deciding whether a patient may benefit from neurology, rehabilitation, vestibular therapy, cognitive support, or other follow-up care.

Clinical Documentation

Support more complete documentation by combining symptoms, timing, history, and biomarker findings.

A Practical Addition to TBI Evaluation

Clear TBI testing is designed to fit into provider workflows without replacing established clinical evaluation. Results may be considered alongside injury history, symptom presentation, neurological assessment, imaging when indicated, and follow-up needs. This gives providers a more complete view of the patient’s injury profile and recovery considerations.

Collect clinical history and symptom information

Add blood-based biomarker testing when appropriate

Use results to support follow-up planning, referral decisions, and documentation

FAQs

Do biomarkers replace imaging or neurological evaluation?
No. Biomarker testing is designed to complement clinical judgment, imaging, and neurological evaluation by adding measurable biological data.
Each biomarker has a different rise, peak, and decline pattern after injury. Collection timing helps providers interpret results in the proper clinical context.
Blood-based biomarkers may provide additional insight into biological response after head trauma, even when traditional evaluation methods do not fully explain symptoms.

Clear TBI is designed for providers evaluating concussion, traumatic brain injury, persistent symptoms, recovery patterns, and long-term neurological risk.

Results should be interpreted as part of the broader clinical picture, including mechanism of injury, symptom presentation, timing of collection, imaging when indicated, and patient-specific risk factors.

Bring Objective TBI Insight Into Your Practice

Clear TBI NeuroLabs helps providers incorporate blood-based biomarker testing into concussion and traumatic brain injury care. Contact us to learn how testing can fit into your clinical workflow.

Scroll to Top